The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial (Q73110411)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1999

Language	Label	Description	Also known as
English	The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial	scientific article published on 01 October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

anticoagulation

1 reference

based on heuristic

inferred from title

author name string

P Alaupovic

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J D Fesmire

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Hunnighake

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Domanski

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Forman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G L Knatterud

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Forrester

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J A Herd

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Hoogwerf

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Campeau

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F L Gobel

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

146

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

369-379

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Quantitative determination of human apolipoprotein C-III by electroimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Tissue distribution of [3H]cholesteryl linoleyl ether-labeled human Lp(a) in different rat organs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Composition of plasma ApoA-I-containing lipoprotein particles in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Statins: is there a need for alternative or adjunctive therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Dose--Response Study of Colestipol Tablets in Patients with Moderate Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900151-3

7 January 2021

Identifiers

10.1016/S0021-9150(99)00151-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532693%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73110411&oldid=1899962060"